55
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Preparation and characterization of ofloxacin microspheres for the eradication of bone associated bacterial biofilm

Pages 27-37 | Published online: 29 Sep 2008

References

  • ANWAR, H., DASGUPTA, M. K., and COSTERT ON, J. W., 1990, Testing the susceptibility of bacteria in biofilms to antibacterials. Antimicrobial Agents and Chemotherapy, 34, 2043–2046.
  • BOISDRON- CELLE, M., MENET, P., and BENOIT, J. p., 1995, Preparation and characterization of 5-fluorouracil-loaded microparticles as biodegradable anticancer drug carriers. Journal of Pharmacy and Pharmacology, 4, 108–114.
  • COSTERTON, J. W., CHENG, K. J., GEESEY, G. G., LADD, T. I., NICKEL, J. C., DASGUPT A, M., and MARRIE, T. J., 1987, Bacterial biohlms in nature and disease. Annual Review of Microbiology, 41, 435–464.
  • FONG, W. J., NAZARENO, P. J., PEARSON, J. E., and MAUDLING, H. V., 1986, Evaluation of biodegradable microspheres prepared by a solvent evaporation process using sodium oleate as emulsifer. Journal of Controlled Release, 3, 119–130.
  • GENTRY, L., and RODRIGUEZ - GOMEZ, G., 1990, Oral ciprofloxacin compared with parenteral antibiotics in the treatment of osteomyelitis. Antimicrobial Agents and Chemo-therapy, 34, 40–43.
  • GENTRY, L., and RODRIGUEZ - GOMEZ, G., 1991, Ofloxacin versus parenteral therapy for chronic osteomyelitis. Antimicrobial Agents and Chemotherapy, 35, 538–541.
  • GRISTINA, A. G., OGA, M., WEBB, L. X., and HOBGOOD, C. D., 1985, Adherent bacterial colonization in the pathogenesis of osteomyelitis. Sciences, 228, 990–993.
  • HOOPER, D. C., and WOLFSON, J. S., 1991. Fluoroquinolone antimicrobial agents. New England Journal of Medicine, 324, 384–394.
  • KLEMM, K., 1981, Septol-a new way of local antibiotic therapy. In Local antibiotic treatment in osteomyelitis and soft-tissue infections, edited by T. J. G. Van Rens and F. H. Kayser (Amsterdam: Excepta Medica), pp. 24–31.
  • LEW, D. P., and WALDVOGEL, F. A., 1995, Quinolones and osteomyelitis: state of the art. Drugs, 49, supp. 2, 100–111.
  • NICKEL, J. C., RUSESKA, I., WRIGHT, J. B., and COST ERTON, J. W., 1985, Tobramycin resistance of Pseudomonas aeruginosa cells growing as a biofilm on urinary catheter material. Antimicrobial Agents and Chemotherapy, 27, 619–624.
  • NORDEN, C. GILLESPIE, W. J., and NADE S., 1994, Infections in bones and joints (Boston: Blackwell Scientific Publication).
  • OKSANEN, C. A., and ZooRAH, G., 1990, The relationship between the glass transition temperature and water vapor absorption of poly(vinylpyrrolidone). Pharmaceutical Research, 7, 654–657.
  • OVERBECK, J. p., WINCKLER, S. T., ME FFERT, R., TORMALA, p., SPIEGEL, H. U., and BRUG, E., 1995, Penetration of ciprcfloxacin into bone: a new bioadsorbable implant. Journal of Investigative Surgery, 8, 155–162.
  • OWUSU-ABABIO, G., and ROGERS, J. A., 1996a, Formulation and release kinetics of cephalexin monohydrate from biodegradable polymeric microspheres. Journal of Micro-encapsulation, 13, 195–205.
  • OWUSU-ABABIO, G., and ROGERS, J. A., 1996b, Formulation and release of ciprcfloxacin from poly(L-lactic acid) microparticles. European Journal of Pharmaceutics and Biopharmaceutics, 42, 188–192.
  • ROORDA, W. E., 1988, Structure and application of hydrogels as drug delivery systems, PhD dissertation, Leiden University, Leiden, The Netherlands.
  • SCHMIDT, C. WENZ, R., and MOLL, F., 1995, Antibiotic in vivo/in vitro, histocompatibility and biodegradation of gentamicin implants based on lactic acid polymers and copolymers. Journal of Controlled Release, 37, 83–94.
  • SHAH, S. S., CHAD, Y., and PITT, C. G., 1992, poly(glycolic acid-co-DL-lactic acid): diffusion or degradation controlled delivery? Journal of Controlled Release, 18, 261–270.
  • STABILE, D. E., and JAcoBs, A. M., 1990, Development and application of antibiotic-loaded bone cement beads. Journal of the American Podiatric Medical Association, 80, 354.–359.
  • WALDVOGEL, F. A., and PAPAGEORGION, P. s., 1980, Osteomyelitis: the past decade. New England Journal of Medicine, 303, 360–370.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.